Trending Now
ARCA Biopharma Inc. (NASDAQ:ABIO) Announces That It Has Received IND Application...
ARCA Biopharma Inc. (NASDAQ:ABIO) has announced that it has received FDA approval for its Investigational New Drug application for AB201 (rNAPc2) as a potential...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
In a landmark development, the U.S. Food and Drug Administration recently endorsed a groundbreaking therapy by Merck, setting a new course for...
MAKE IT MODERN
LATEST REVIEWS
Recent Stock Ratings: Insights from Top Financial Firms (CVS,DT,SE,HE,PTON)
In the fast-evolving stock market, premier financial institutions diligently analyze companies to make judicious decisions. Here are some of the recent ratings...
MAKE IT MODERN
PERFORMANCE TRAINING
ISW Holdings Inc (OTCMKTS:ISWH) New Crypto Mining Technology Ready for Primetime
As the price of Bitcoin goes soaring higher, investors unwilling or unable to put money to work in the cryptocurrency market, itself, as an...
Why the EV Pullback Could be a Once-in-a-Lifetime Opportunity for Investors (TSLA, DSGT, XPEV,...
If there’s one stat that really shows the growth potential in the electric vehicle space over coming years, it’s this: EVs accounted...
Pasithea Therapeutics Corp (NASDAQ: KTTA) Opens Second Clinic in London For IV Ketamine Therapy...
Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced that its subsidiary, Pasithea Clinics, has opened a second clinical in Marylebone that offers intravenous ketamine therapy...
FDA Grants Clearance of IND for TNX-102 SL from Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) boasts of a wide portfolio of central nervous system (CNS) and immunology product candidates. The latter candidates include vaccines,...
Aptose Biosciences (NASDAQ:APTO) Announce Dosing of First AML Patient In CG-806 Study
Aptose Biosciences Inc. (NASDAQ:APTO) has announced the dosing of the first acute myeloid leukemia (AML) patient in Phase 1 a/b CG-806 clinical study.
CG-806 inhibits...
MAKE IT MODERN
